Literature DB >> 30229373

Hematopoietic stem cell and mesenchymal stem cell population size in bone marrow samples depends on patient's age and harvesting technique.

Katja Rebolj1, Matija Veber2, Matej Drobnič3, Elvira Maličev4.   

Abstract

Mesenchymal stem cells (MSCs) are heterogeneous population of cells with great potential for regenerative medicine. MSCs are relatively easy to expand in a cell culture, however determination of their concentration in harvested tissue is more complex and is not implemented as routine procedure. To identify MSCs collected from bone marrow we have used two combinations of cell markers (CD45-/CD73+/CD90+/CD105+ and CD45-/CD271+) and fibroblast colony-forming unit (CFU-F) assay. Further, in donors of various ages, mesenchymal stem cell concentration was compared with the result of CFU-F assay and with hematopoietic stem cell concentration, determined by a standardized flow cytometric assay. A positive correlation of MSC populations to the CFU-F numbers is observed, the population of the CD45-/CD271+ cells correlates better with CFU-F numbers than the population of the CD45-/CD73+/CD90+/CD105+ cells. The relationship between the hematopoietic CD45dim/CD34+ cell concentration and mesenchymal CFU-Fs or CD45-/CD271+ cells shows a positive linear regression. An age-related quantitative reduction of hematopoietic CD45dim/CD34+, mesenchymal CD45-/CD73+/CD90+/CD105+ and CD45-/CD271+ stem cells, and CFU-F numbers were noted. Additionally, statistically significant higher CFU-F numbers were observed when bone marrow samples were harvested from three different sites from the anterior iliac crest instead of harvesting the same sample amount only from one site.

Entities:  

Keywords:  Bone marrow; CD271+ cells; CFU-F assay; Hematopoietic stem cells; Mesenchymal stem cells

Year:  2018        PMID: 30229373      PMCID: PMC6269357          DOI: 10.1007/s10616-018-0250-4

Source DB:  PubMed          Journal:  Cytotechnology        ISSN: 0920-9069            Impact factor:   2.058


  29 in total

1.  Single-platform quality control assay to quantify multipotential stromal cells in bone marrow aspirates prior to bulk manufacture or direct therapeutic use.

Authors:  Richard Cuthbert; Sally A Boxall; Hiang Boon Tan; Peter V Giannoudis; Dennis McGonagle; Elena Jones
Journal:  Cytotherapy       Date:  2012-01-24       Impact factor: 5.414

2.  Percutaneous autologous bone-marrow grafting for nonunions. Influence of the number and concentration of progenitor cells.

Authors:  Ph Hernigou; A Poignard; F Beaujean; H Rouard
Journal:  J Bone Joint Surg Am       Date:  2005-07       Impact factor: 5.284

3.  The CD271 expression could be alone for establisher phenotypic marker in Bone Marrow derived mesenchymal stem cells.

Authors:  Edgardo Flores-Torales; Arturo Orozco-Barocio; Oscar R Gonzalez-Ramella; Antonio Carrasco-Yalan; Karlen Gazarian; Silvio Cuneo-Pareto
Journal:  Folia Histochem Cytobiol       Date:  2010-12       Impact factor: 1.698

4.  CD271 antigen defines a subset of multipotent stromal cells with immunosuppressive and lymphohematopoietic engraftment-promoting properties.

Authors:  Selim Kuçi; Zyrafete Kuçi; Hermann Kreyenberg; Erika Deak; Kathrin Pütsch; Sabine Huenecke; Chandrasekhar Amara; Stefanie Koller; Eva Rettinger; Manuel Grez; Ulrike Koehl; Hatixhe Latifi-Pupovci; Reinhard Henschler; Torsten Tonn; Dorothee von Laer; Thomas Klingebiel; Peter Bader
Journal:  Haematologica       Date:  2010-02-23       Impact factor: 9.941

5.  Age-related changes in human hematopoietic stem/progenitor cells.

Authors:  Klaudia Kuranda; Jacques Vargaftig; Philippe de la Rochere; Christine Dosquet; Dominique Charron; Florence Bardin; Cecile Tonnelle; Dominique Bonnet; Michele Goodhardt
Journal:  Aging Cell       Date:  2011-03-22       Impact factor: 9.304

Review 6.  Making sense of hematopoietic stem cell niches.

Authors:  Philip E Boulais; Paul S Frenette
Journal:  Blood       Date:  2015-03-11       Impact factor: 22.113

7.  The composition of the mesenchymal stromal cell compartment in human bone marrow changes during development and aging.

Authors:  Marijke W Maijenburg; Marion Kleijer; Kim Vermeul; Erik P J Mul; Floris P J van Alphen; C Ellen van der Schoot; Carlijn Voermans
Journal:  Haematologica       Date:  2011-10-11       Impact factor: 9.941

8.  Collection and immunoselection of CD34+ cells: the impact of age, sex, and diabetes in patients with chronic heart failure.

Authors:  Petra Konecnik Kresnik; Metka Krasna; Primoz Rozman; Bojan Vrtovec; Elvira Malicev
Journal:  Transfusion       Date:  2016-05-17       Impact factor: 3.157

9.  Cotransplantation of haploidentical hematopoietic and umbilical cord mesenchymal stem cells with a myeloablative regimen for refractory/relapsed hematologic malignancy.

Authors:  Yamei Wu; Zhihong Wang; Yongbin Cao; Lixin Xu; Xiaohong Li; Pei Liu; Pei Yan; Zhouyang Liu; Dandan Zhao; Jing Wang; Xiaoxiong Wu; Chunji Gao; Wanming Da; Zhongchao Han
Journal:  Ann Hematol       Date:  2013-07-11       Impact factor: 3.673

Review 10.  Hematopoietic stem cell transplantation: a review and recommendations for follow-up care for the general practitioner.

Authors:  Jakob R Passweg; Jörg Halter; Christoph Bucher; Sabine Gerull; Dominik Heim; Alicia Rovó; Andreas Buser; Martin Stern; André Tichelli
Journal:  Swiss Med Wkly       Date:  2012-10-15       Impact factor: 2.193

View more
  6 in total

Review 1.  Endogenous Mobilization of Mesenchymal Stromal Cells: A Pathway for Interorgan Communication?

Authors:  Amandine Girousse; Maxime Mathieu; Quentin Sastourné-Arrey; Sylvie Monferran; Louis Casteilla; Coralie Sengenès
Journal:  Front Cell Dev Biol       Date:  2021-01-08

Review 2.  Cell Sources for Human In vitro Bone Models.

Authors:  Sana Ansari; Keita Ito; Sandra Hofmann
Journal:  Curr Osteoporos Rep       Date:  2021-01-15       Impact factor: 5.096

Review 3.  Bone Marrow Multipotent Mesenchymal Stromal Cells as Autologous Therapy for Osteonecrosis: Effects of Age and Underlying Causes.

Authors:  Jehan J El-Jawhari; Payal Ganguly; Elena Jones; Peter V Giannoudis
Journal:  Bioengineering (Basel)       Date:  2021-05-17

4.  The Effect of Intracoronary Infusion of Autologous Bone Marrow-Derived Lineage-Negative Stem/Progenitor Cells on Remodeling of Post-Infarcted Heart in Patient with Acute Myocardial Infarction.

Authors:  Małgorzata Peregud-Pogorzelska; Krzysztof Przybycień; Bartłomiej Baumert; Maciej Kotowski; Ewa Pius-Sadowska; Krzysztof Safranow; Jarosław Peregud-Pogorzelski; Zdzisława Kornacewicz-Jach; Edyta Paczkowska; Bogusław Machaliński
Journal:  Int J Med Sci       Date:  2020-04-06       Impact factor: 3.738

Review 5.  Bone Marrow Aspirate Matrix: A Convenient Ally in Regenerative Medicine.

Authors:  José Fábio Lana; Lucas Furtado da Fonseca; Gabriel Azzini; Gabriel Santos; Marcelo Braga; Alvaro Motta Cardoso Junior; William D Murrell; Alberto Gobbi; Joseph Purita; Marco Antonio Percope de Andrade
Journal:  Int J Mol Sci       Date:  2021-03-09       Impact factor: 5.923

Review 6.  Application of Orthobiologics in Achilles Tendinopathy: A Review.

Authors:  Luciano C Ramires; Madhan Jeyaraman; Sathish Muthu; Navaladi Shankar A; Gabriel Silva Santos; Lucas Furtado da Fonseca; José Fábio Lana; Ramya Lakshmi Rajendran; Prakash Gangadaran; Manasi P Jogalekar; Alfredo A Cardoso; Alex Eickhoff
Journal:  Life (Basel)       Date:  2022-03-09
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.